Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Lymphoid 2CNS 1Breast 1

Conditions

Lymphoma 84Lymphoma, Non-Hodgkin 82Precursor Cell Lymphoblastic Leukemia-Lymphoma 79Leukemia, Lymphocytic, Chronic, B-Cell 65Lymphoma, Large B-Cell, Diffuse 49Lymphoma, Follicular 49Hodgkin Disease 39Burkitt Lymphoma 38Recurrence 35Multiple Myeloma 33Leukemia, Myeloid, Acute 32Leukemia 32Lymphoma, Mantle-Cell 30Lymphoma, B-Cell 28Neoplasms 22Myelodysplastic Syndromes 22Hematologic Neoplasms 21Waldenstrom Macroglobulinemia 16Lymphoma, B-Cell, Marginal Zone 16Leukemia, Myelogenous, Chronic, BCR-ABL Positive 14Leukemia, B-Cell 14Sarcoma 12Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 10Lymphoma, T-Cell, Peripheral 10Lymphoma, T-Cell 10Lymphoma, Large-Cell, Anaplastic 10Glioma 10Osteosarcoma 9Neuroblastoma 9Mycosis Fungoides 9

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Cognitive Dysfunction × Lymphoid × 30 days × Clear all
NCT06745583 2026-06-03

A Phase 2 Study to Assess the Safety of EI-1071 and the Effects of EI-1071 on Neuroinflammation in Alzheimer's Disease Patients

Elixiron Immunotherapeutics (Hong Kong) Ltd.

Phase 2 Recruiting
15 enrolled
Lymphoid

Neuroinflammatory Diseases, Alzheimer Disease, Lymphoma, Follicular, Neurodegenerative Diseases, Cognitive Dysfunction

NCT07596186 2026-05-19

0150-24 SOR

Soroka University Medical Center

Active not recruiting
98 enrolled
Lymphoid

Dementia, Lymphoma, Follicular, Cognitive Dysfunction

Data powered by HemOnc (CC BY 4.0) Colophon âš¡